Introduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen

Size: px
Start display at page:

Download "Introduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen"

Transcription

1 Introduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen European Life Sciences Infrastructure for Biological Information europe.org

2 ELIXIR connects national bioinformatics centres and EMBL EBI into a sustainable European infrastructure for biological research data medicine agriculture 2 environment bioindustries ELIXIR underpins life science research across academia and industry

3 The data challenge: Volume Gigabytes N Databases

4 The data challenge: Geographically disperse Data production sites increasing across Europe European Illumina sales up 20% 2o14 Source: 4

5 The data challenge: diversity databases Diverse Plentiful Disperse Nucleic Acids Research annual Database Issue and the NAR online Molecular Biology Database Collection in MY Galperin, GR Cochrane Nucleic Acids Research, 2011

6 An international distributed infrastructure for Data Standards Tools Compute Training Industry

7 A distributed infrastructure scales with the challenges ELIXIR deliver services through national ELIXIR Nodes ELIXIR Nodes build local bioinformatics capacity throughout Europe ELIXIR Nodes build on national strengths and priorities 7

8 ELIXIR funding Hub funded jointly by ELIXIR member states Nodes funded by national agencies Joint applications to EU funding

9 ELIXIR Nodes Over 100 institutes involved in ELIXIR Nodes Collaboration Agreements to be signed between Hub and Nodes Nodes that are national networks are developing own internal Node agreements 9

10 ELIXIR Core Data Resources Small subset of ELIXIR data resources and archives Fundamental importance to life science Long term preservation and reuse of biological data Focal point of ELIXIR s technical and science policy actions for data sustainability

11 ELIXIR Named Services Quality indicator of the Service or Tool have clearly outlined terms of usage, declared service levels and monitoring vetted by the ELIXIR SAB as part of Node application Sustainability & Commitment to Service Described in Service Delivery Plans annexed to the Hub Node Collaboration Agreements

12 ELIXIR tools and data registry

13 Integration and interoperability of resources typically 40% of our effort in biomarker discovery is data integration J. Wojcik, CEO, Quartz Bio Formats, Ontologies, Guidelines, 13 Professional skills for managing and exploiting data

14 Data interoperability Human Protein Atlas The Human Protein Atlas portal is a publicly available database with millions of high-resolution images showing the spatial distribution of proteins in 46 different normal human tissues and 20 different cancer types, as well as 47 different human cell lines.

15 ELIXIR pilots to address key challenges in biomedical research: 1. Cloud computing Embassy cloud : Access reference data in a virtual environment work as though you are at EMBL-EBI or SIB, Switzerland 2. Authentication & Authorisation Improved methods and processes for access to clinical data 3. High-Performance Computing Lightpath : Connections for on-demand reference data to remote HPC centres at EMBL-EBI and CSC Finland

16 ELIXIR prioritised by ESFRI and Council of EU

17 ELIXIR EXCELERATE ELIXIR s application following ESFRI Prioritisation in 2014 Results expected in Spring; project start Summer Eur 19 million 4 year project Focus on accelerating the implementation of ELIXIR Use case on Plant Sciences: Integrating Genomic and Phenotypic Data for Crop and Forest Plants

18 ELIXIR Industry Advisory Committee Philippe Sanseau, GlaxoSmithKline, UK Wendy Filsell, Unilever R&D, UK (Vice Chair) Angel Pizarro, Amazon Web Services, USA Jakob de Vlieg, Bayer CropSciences Innovation Center, Belgium Martin Ebeling, Hoffmann La Roche, Switzerland Anita Eliasson, Biocomputing Platforms Ltd, Finland Mark Forster, Syngenta, UK (Chair) Montserrat Vendrell, Biocat, Spain Natalia Jiménez Lozano, Bull and Atos, Spain Iain Hrynaszkiewicz, Nature Publishing Group Macmillan, UK Claus Stie Kallesøe, Gritsystems A/S, Denmark 18

19 Industry Advisory Committee

20 Public data: a foundation for innovation Supporting Europe s SMEs that build services on top of the public bioinformatics resources understanding impact ELIXIR Core Resources and Named Services Facilitating integration through Pilot Actions

21 Innovation and SME programme Copenhagen, November 2014 Focussed on pharma and ELIXIR resources for drug discovery Wageningen, March 2015 Data driven growth in the agri food industries Basel, 9 June 2015 Pharma and biotech Future events? Marine informatics HPC suppliers

22 Benefit of ELIXIR to industry supplier The life science sector as a consumer of HPC is already high and set to increase further 22

23 ELIXIR industry distribution channel Mailing list of around 200 companies and SME Associations Events, news and industry/academia funding opportunities from across ELIXIR Content, reach and frequency to expand through 2015

24 ELIXIR webinars Regular series of updates from ELIXIR Typically 3 rd Wednesday of month 30 minute talk: 30 min questions Future webinars: Data and Software carpentry Aleksandra Pawlik Marine metagenimics: towards user centric services Nils Peder Willassen Run using WebEx for live or recorded viewing Full programme: elixir europe.org/webinar 24

25 Thank you europe.org

ELIXIR connects national centres and EMBL EBI to build a sustainable European infrastructure for biological research data. medicine.

ELIXIR connects national centres and EMBL EBI to build a sustainable European infrastructure for biological research data. medicine. ELIXIR connects national centres and EMBL EBI to build a sustainable European infrastructure for biological research data. medicine agriculture 1 environment bioindustries ELIXIR underpins life science

More information

Tools, techniques and infrastructure bioinformatics in marine biotechnology

Tools, techniques and infrastructure bioinformatics in marine biotechnology Tools, techniques and infrastructure bioinformatics in marine biotechnology Second Marine Biotechnology ERA-NET Stakeholder Meeting 13 th - 14 th October 2016, Hotel Marivaux, Brussels, Belgium Nils Peder

More information

ELIXIR: data for molecular biology and points of entry for marine scientists

ELIXIR: data for molecular biology and points of entry for marine scientists ELIXIR: data for molecular biology and points of entry for marine scientists Guy Cochrane, EMBL-EBI EuroMarine 2018 General Assembly meeting 17-18 January 2018 www.elixir-europe.org Scales of molecular

More information

Interpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI

Interpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI Interpreting Genome Data for Personalised Medicine Professor Dame Janet Thornton EMBL-EBI Deciphering a genome 3 billion bases 4 million variants 21,000 coding variants 10,000 non-synonymous variants 50-100

More information

Elixir: European Bioinformatics Research Infrastructure. Rolf Apweiler

Elixir: European Bioinformatics Research Infrastructure. Rolf Apweiler Elixir: European Bioinformatics Research Infrastructure Rolf Apweiler EMBL-EBI Service Mission To enable life science research and its translation to medicine, agriculture, the bioindustries and society

More information

ELIXIR KPI framework and alignment of KPIs between e-infrastructures and research infrastructures

ELIXIR KPI framework and alignment of KPIs between e-infrastructures and research infrastructures ELIXIR KPI framework and alignment of KPIs between e-infrastructures and research infrastructures Rafael C Jimenez, ELIXIR CTO June 8, 2017 e-irg workshop June 2017 www.elixir-europe.org ELIXIR European

More information

European Genome phenome Archive at the European Bioinformatics Institute. Helen Parkinson Head of Molecular Archives

European Genome phenome Archive at the European Bioinformatics Institute. Helen Parkinson Head of Molecular Archives European Genome phenome Archive at the European Bioinformatics Institute Helen Parkinson Head of Molecular Archives What is EMBL-EBI? International, non-profit research institute Part of the European Molecular

More information

ELIXIR Service portfolio management

ELIXIR Service portfolio management ELIXIR Service portfolio management ELIXIR Types of services Governance structure Portfolio management Compliant services? Rafael C Jimenez, CTO EOSC stakeholder forum Nov 29, 2017 www.elixir-europe.org

More information

A framework for quality management in the biomedical research infrastructures (BMS RIs)

A framework for quality management in the biomedical research infrastructures (BMS RIs) Common BMS RI Framework for Quality Management A framework for quality management in the biomedical research infrastructures (BMS RIs) BMS RIs put quality at the heart of biomedical research It has been

More information

WP4: Data services and reporting standards

WP4: Data services and reporting standards WP4: Data services and reporting standards WP leader Guy Cochrane EMBL-EBI WP co-leader Nils-Peder Willassen UiT Task 4.1 leader Jeena Rajan EMBL-EBI Task 4.2 leader Jeena Rajan EMBL-EBI Task 4.3 leader

More information

WP2 Legal, Governance & Ethical Issues

WP2 Legal, Governance & Ethical Issues WP2 Legal, Governance & Ethical Issues Stakeholder Meeting in Heidelberg 30 January 2012 Co- Chairs Dr. Edvard Beem, ZonMW, NL Dr. Silke Schumacher, EMBL WP2 Deliverables Deliverables by January 2012:

More information

Von Mäusen und Menschen Datenbrücken verbessern den Zugang zu Forschungsdaten in INFRAFRONTIER

Von Mäusen und Menschen Datenbrücken verbessern den Zugang zu Forschungsdaten in INFRAFRONTIER Von Mäusen und Menschen Datenbrücken verbessern den Zugang zu Forschungsdaten in INFRAFRONTIER Michael Raess & Philipp Gormanns, Helmholtz Zentrum München Helmholtz Open Access Webinars 16 and 24 July

More information

Professor Ewan Birney FRS Director, EMBL-EBI

Professor Ewan Birney FRS Director, EMBL-EBI Infrastructures for research and innovation Professor Ewan Birney FRS Director, EMBL-EBI www.ebi.ac.uk Outline of talk Who Am I, What is EMBL? The change in genomics The needs for stratified patients in

More information

INNOVATIVE CONCEPTS ON DATA GENERATION AND USE FOR PERSONALISED MEDICINE RESEARCH

INNOVATIVE CONCEPTS ON DATA GENERATION AND USE FOR PERSONALISED MEDICINE RESEARCH Data collection and Management in PM Research Alfonso Valencia ICREA Research Professor Director, Life Sciences Department BSC Director, Spanish National Bioinformatics Institute (INB-ISCIII) Head of the

More information

Access to Information from Molecular Biology and Genome Research

Access to Information from Molecular Biology and Genome Research Future Needs for Research Infrastructures in Biomedical Sciences Access to Information from Molecular Biology and Genome Research DG Research: Brussels March 2005 User Community for this information is

More information

- OMICS IN PERSONALISED MEDICINE

- OMICS IN PERSONALISED MEDICINE SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary

More information

The EMBL-Bioinformatics and Data-Intensive Informatics

The EMBL-Bioinformatics and Data-Intensive Informatics The EMBL-Bioinformatics and Data-Intensive Informatics Graham Cameron EMBL-EBI What is the EMBL-EBI? Non-profit organization Part of the European Molecular Biology Laboratory Based on the Wellcome Trust

More information

EESI Final Conference

EESI Final Conference FP7 Support Action - European Exascale Software Initiative DG Information Society and the unit e-infrastructures EESI Final Conference EESI WG3.4: Life Sciences and Health Modesto Orozco, Chair Janet Thornton,

More information

Computational Challenges in Life Sciences Research Infrastructures

Computational Challenges in Life Sciences Research Infrastructures Computational Challenges in Life Sciences Research Infrastructures Alvis Brazma European Bioinformatics Institute European Molecular Biology Laboratory European Bioinformatics Institute (EBI) EBI is in

More information

Nordic Register and Biobank Data

Nordic Register and Biobank Data Nordic Register and Biobank Data A basis for innovative research on health and welfare Juni Palmgren Karolinska Institutet, Stockholm Nordic conference on Real World Data Helsinki November 2016 Nordic

More information

European Molecular Biology Laboratory

European Molecular Biology Laboratory European Molecular Biology Laboratory Laboratoire Européen de Biologie Moléculaire Europäisches Laboratorium für Molekularbiologie Prof. Iain W. Mattaj, Director General EMBL Member States Austria 1974

More information

EMBL-EBI Overview EMBL-EBI Overview

EMBL-EBI Overview EMBL-EBI Overview EMBL-EBI Overview Welcome Welcome to the European Bioinformatics Institute (EMBL-EBI), a global hub for big data in biology. We promote scientific progress by providing freely available data to the life-science

More information

Commercialising Genomic Research 1-3 October 2018

Commercialising Genomic Research 1-3 October 2018 Course Programme Commercialising Genomic Research 1-3 October 2018 Wellcome Genome Campus Hinxton, Cambridge, UK Monday 1 October 2018 09:30-10:00 Registration with refreshments 10:00-10:30 Introduction

More information

SafeSciMET. European Modular Education and Training Programme in Safety Sciences for Medicines

SafeSciMET. European Modular Education and Training Programme in Safety Sciences for Medicines SafeSciMET European Modular Education and Training Programme in Safety Sciences for Medicines What patients need What Europe needs Rapid exploitation of insights in disease mechanisms for introduction

More information

Elixir: Overview, Progress and Futures

Elixir: Overview, Progress and Futures Elixir: Overview, Progress and Futures 20th Meeting of the EC-US Biotechnology Task Force Barcelona 3 June 2010 Andrew Lyall, ELIXIR Project Manager www.elixir-europe.org ELIXIR: a sustainable infrastructure

More information

Open PHACTS: Semantic interoperability for drug discovery

Open PHACTS: Semantic interoperability for drug discovery Open PHACTS: Semantic interoperability for drug discovery ACS National Meeting, San Diego Herman van Vlijmen 16 Mar 2016 Judith Hinton Andrew, Rock Composite 22 Artwork from The Creative Center What is

More information

Future of the Project. BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton

Future of the Project. BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton Future of the Project BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton What were goals of BioMedBridges? GOAL 1: To provide computational data and service bridges between

More information

Generation of research tools to translate genomic discoveries into drug discovery projects. Nils Ostermann, Novartis

Generation of research tools to translate genomic discoveries into drug discovery projects. Nils Ostermann, Novartis Generation of research tools to translate genomic discoveries into drug discovery projects Nils Ostermann, Novartis Need for public-private collaboration Common interest Genomic information is growing

More information

ELIXIR-GREECE Babis Savakis ELIXIR-GREECE kick-off meeting NHRF, Athens 18 May 2018

ELIXIR-GREECE Babis Savakis ELIXIR-GREECE kick-off meeting NHRF, Athens 18 May 2018 ELIXIR-GREECE Babis Savakis ELIXIR-GREECE kick-off meeting NHRF, Athens 18 May 2018 www.elixir-greece.org ELIXIR Membership ELIXIR-Greece CERTH U. of Thessaloniki U. of Ioannina Thessaloniki Alexandroupolis

More information

Topic: Genome-Environment Interactions in Inflammatory Skin Disease

Topic: Genome-Environment Interactions in Inflammatory Skin Disease Topic: Genome-Environment Interactions in Inflammatory Skin Disease All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls will be

More information

KPI Definition Comment Relates to Baseline Target

KPI Definition Comment Relates to Baseline Target IMI2 Key performance indicators (KPIs) Reporting on measuring and outcomes on the ten following Key Performance Indicators will be provided yearly as part of the IMI2 JU Annual Activity Reports for year

More information

The Open Pharmacological Concepts Triple Store

The Open Pharmacological Concepts Triple Store The Open Pharmacological Concepts Triple Store Gerhard F. Ecker Dept Medicinal Chemistry, Univ Vienna Gerhard.f.ecker@univie.ac.at; www.openphacts.org The Innovative Medicines Initiative EC funded public-private

More information

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International

More information

ELIXIR DK. Danish National Supercomputer for Life Sciences. European Life Sciences Infrastructure for Biological Information europe.

ELIXIR DK. Danish National Supercomputer for Life Sciences. European Life Sciences Infrastructure for Biological Information  europe. ELIXIR DK Danish National Supercomputer for Life Sciences European Life Sciences Infrastructure for Biological Information www.elixir europe.org National need for life science supercomputer Approx. 2%

More information

Webinar IMI2 Call 14 Opportunities for SMEs

Webinar IMI2 Call 14 Opportunities for SMEs Webinar IMI2 Call 14 Opportunities for SMEs 19 March 2018 Agenda How to use GoToWebinar Catherine Brett, IMI Opportunities for SMEs Colm Carroll, IMI Questions & answers How to use GoToWebinar - audio

More information

Biomarker discovery. Enabling pharmaceutical and biotech partners to discover relevant biomarkers in diseases of interest

Biomarker discovery. Enabling pharmaceutical and biotech partners to discover relevant biomarkers in diseases of interest Biomarker discovery Enabling pharmaceutical and biotech partners to discover relevant biomarkers in diseases of interest Biomarker discovery A biomarker is a measurable indicator of the severity or presence

More information

M a x i m i z in g Value from NGS Analytics in t h e E n terprise

M a x i m i z in g Value from NGS Analytics in t h e E n terprise Global Headquarters: 5 Speen Street Framingham, MA 01701 USA P.508.935.4445 F.508.988.7881 www.idc-hi.com M a x i m i z in g Value from NGS Analytics in t h e E n terprise C U S T O M I N D U S T R Y B

More information

TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298

TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 DIAGNOSTICS BUSINESS ANALYSIS SERIES: TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 By ADAMS BUSINESS ASSOCIATES March 2017. March 2017 ABA 298 1 Technologies, Products & Services

More information

Dr. Thibaud Mascart. ERA-MBT final conference Oceans of opportunities. Oslo, 20 Nov 2017

Dr. Thibaud Mascart. ERA-MBT final conference Oceans of opportunities. Oslo, 20 Nov 2017 Dr. Thibaud Mascart ERA-MBT final conference Oceans of opportunities Oslo, 20 Nov 2017 Enabling technologies and infrastructure there remains an acute need to continue to build research and innovation

More information

ACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes

ACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes ACCELERATING GENOMIC ANALYSIS ON THE CLOUD Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia

More information

EU Big Data Initiatives

EU Big Data Initiatives European Network of Excellence for Big Data in Hematology, consisting of 51 partners from 11 countries. Aliki Taylor, HARMONY Alliance Partner Director Global Health Outcomes, Takeda EU Big Data Initiatives

More information

TRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS. H a n n s Lochmüller, Newcastle University

TRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS. H a n n s Lochmüller, Newcastle University TRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS H a n n s Lochmüller, Newcastle University Addressing the translational pathway 2 Trials Gene identification/ pathophysiology

More information

High peformance computing infrastructure for bioinformatics

High peformance computing infrastructure for bioinformatics High peformance computing infrastructure for bioinformatics Scott Hazelhurst University of the Witwatersrand December 2009 What we need Skills, time What we need Skills, time Fast network Lots of storage

More information

Global Biomolecular Information Infrastructure and Australia. Graham Cameron Director The EMBL Australia Bioinformatics Resource

Global Biomolecular Information Infrastructure and Australia. Graham Cameron Director The EMBL Australia Bioinformatics Resource Global Biomolecular Information Infrastructure and Australia Graham Cameron Director The EMBL Australia Bioinformatics Resource What is bioinformatics? Methods, data, IT to exploit biomolecular information

More information

Innovative Medicines Initiative

Innovative Medicines Initiative Innovative Medicines Initiative EMA - EBE Regulatory Conference on ATMPs Salah-Dine Chibout, Novartis Global Head Discovery & Investigative Safety/ Global Head Preclinical Safety Therapeutic Areas IMI

More information

ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure

ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure Marialuisa Lavitrano Università Milano-Bicocca Coordinatore BBMRI-Italia

More information

The European Bioinformatics Institute - Cambridge. Overview

The European Bioinformatics Institute - Cambridge. Overview The European Bioinformatics Institute - Cambridge Overview European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus Hinxton, Cambridge CB10 1SD United Kingdom y www.ebi.ac.uk C +44 (0)1223 494

More information

BioXplain The Alliance for Integrative Biology The First Open Platform for Iterative, Predictive and Integrative Biology

BioXplain The Alliance for Integrative Biology The First Open Platform for Iterative, Predictive and Integrative Biology The Alliance for Integrative Biology The First Open Platform for Iterative, Predictive and Integrative Biology BioXplain 2009 Pharma R&D critical challenge Despite increasing investments in Technology

More information

Bioinformatics: Present & Future from an EBI Perspective. Janet Thornton. UCL February 14 th 2012

Bioinformatics: Present & Future from an EBI Perspective. Janet Thornton. UCL February 14 th 2012 Bioinformatics: Present & Future from an EBI Perspective Janet Thornton UCL February 14 th 2012 What is bioinformatics? The science of storing, retrieving and analysing large amounts of biological information

More information

Webinar IMI2 Call 14 Development of a platform for federated and privacy-preserving machine learning in support of drug discovery

Webinar IMI2 Call 14 Development of a platform for federated and privacy-preserving machine learning in support of drug discovery Webinar IMI2 Call 14 Development of a platform for federated and privacy-preserving machine learning in support of drug discovery 16 March 2018 Agenda How to use GoToWebinar Catherine Brett, IMI Introduction

More information

October 6, Below we provide input from our community of health informatics experts regarding select portions of the Draft Guidance.

October 6, Below we provide input from our community of health informatics experts regarding select portions of the Draft Guidance. Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Submitted electronically via http://www.regulations.gov RE: Use of Public Human Genetic

More information

The Innovative Medicines Initiative: Building new models of collaborative research across Europe

The Innovative Medicines Initiative: Building new models of collaborative research across Europe The Innovative Medicines Initiative: Building new models of collaborative research across Europe Elisabetta Vaudano IMI, Belgium www.imi.europa.eu What is IMI? An European Public-Private Partnership Focused

More information

Orphan Medicinal Products

Orphan Medicinal Products Development process of Orphan Medicinal Products 1 Did you know that... A rare disease is officially defined as a lifethreatening or chronically debilitating condition that affects no more than 5 in 10,000

More information

The Innovative Medicines Initiative

The Innovative Medicines Initiative The Innovative Medicines Initiative Innovative funding for biotechs & SMEs in Europe Pierre Meulien, IMI Executive Director BIO-Europe Conference, Copenhagen 06.11.2018 IMI Europe s partnership for health

More information

Q4. WORK STREAMS Discovery, Cloud, Large Scale Genomics. DRIVER PROJECTS ELIXIR Beacon, EVA/EGA/ENA. WORK STREAMS Discovery

Q4. WORK STREAMS Discovery, Cloud, Large Scale Genomics. DRIVER PROJECTS ELIXIR Beacon, EVA/EGA/ENA. WORK STREAMS Discovery 2018 - Q4 Search The GA4GH Search API enables a search engine for genomic and clinical data by providing specification for query language across genomic, phenotypic, and clinical data that can be used

More information

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER

More information

EMMA - European Mouse Mutant Archive Michael Hagn

EMMA - European Mouse Mutant Archive Michael Hagn EMMA - European Mouse Mutant Archive Michael Hagn EMMA - European Mouse Mutant Archive OVERVIEW EMMA objectives EMMA network EMMA archive statistics EMMA projects Infrafrontier Key Objectives of EMMA Archiving

More information

Welcome to the Ministry of Foreign Affairs

Welcome to the Ministry of Foreign Affairs Welcome to the Ministry of Foreign Affairs indk@um.dk www.investindk.com National Experimental Therapy Partnership (NEXT) NEXT is a public-private partnership within clinical research offering a one stop

More information

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.

More information

IRDiRC: International Rare Diseases Research Consortium

IRDiRC: International Rare Diseases Research Consortium IRDiRC: International Rare Diseases Research Consortium EuRenomics, NEUROMICS and RD-Connect Joint Kick-off Meeting Sitges, Spain, 25 January 2013 Dr. Iiro Eerola Scientific Project Officer Unit for Personalised

More information

What has Open PHACTS done so far? Lee Harland On behalf of the Open PHACTS Consortium

What has Open PHACTS done so far? Lee Harland On behalf of the Open PHACTS Consortium What has Open PHACTS done so far? Lee Harland On behalf of the Open PHACTS Consortium Pre-competitive Informatics: Pharma are all accessing, processing, storing & re-processing external research data Literature

More information

Present and Future ehealth Research Activities supported by DG INFSO. Gérard Comyn,

Present and Future ehealth Research Activities supported by DG INFSO. Gérard Comyn, Present and Future ehealth Research Activities supported by DG INFSO Gérard Comyn, Head of Unit, ICT for Health, European Commission gerard.comyn@cec.eu.int Some facts Health care expenditure worldwide

More information

Introduction to BIOINFORMATICS

Introduction to BIOINFORMATICS Introduction to BIOINFORMATICS Antonella Lisa CABGen Centro di Analisi Bioinformatica per la Genomica Tel. 0382-546361 E-mail: lisa@igm.cnr.it http://www.igm.cnr.it/pagine-personali/lisa-antonella/ What

More information

BioXplain The Alliance for Integrative Biology

BioXplain The Alliance for Integrative Biology The Alliance for Integrative Biology The First Open Platform for Iterative, Predictive and Integrative Biology Manuel GEA Co-founder & CEO Bio-Modeling Systems BioXplain 2009 Pharma R&D critical challenge

More information

Developments in BioPharma Grid Computing. Rowan Gardner, BioLauncher Ltd

Developments in BioPharma Grid Computing. Rowan Gardner, BioLauncher Ltd Developments in BioPharma Grid Computing Rowan Gardner, BioLauncher Ltd PharmaGRID 2004 60 Delegates, a beautiful location, good food and excellent speakers Speakers Prof. Denis Noble, Applications in

More information

Introduction to EMBL-EBI.

Introduction to EMBL-EBI. Introduction to EMBL-EBI www.ebi.ac.uk What is EMBL-EBI? Part of EMBL Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, the Netherlands,

More information

Drug Discovery insights. Building

Drug Discovery insights. Building DDin Drug Discovery insights Building Bridges TO ACCELERATE DRUG DISCOVERY The Valley of death Basic Research Applied Research Technology Development & Demonstration Product Commercialization & Market

More information

A European Public-Private Partnership! in Healthcare! Michel Goldman, MD,PhD Executive Director

A European Public-Private Partnership! in Healthcare! Michel Goldman, MD,PhD Executive Director A European Public-Private Partnership! in Healthcare! Michel Goldman, MD,PhD Executive Director ITMAT 2010, 27 October 2010 EFPIA Member Companies Participating companies (September 2010):! Innovative

More information

EIB Support in Life Sciences. Shiva Dustdar Head of Division, Innovation Finance Advisory European Investment Bank BIO-Europe Berlin, 7 November 2017

EIB Support in Life Sciences. Shiva Dustdar Head of Division, Innovation Finance Advisory European Investment Bank BIO-Europe Berlin, 7 November 2017 EIB Support in Life Sciences Shiva Dustdar Head of Division, Innovation Finance Advisory European Investment Bank BIO-Europe Berlin, 7 November 2017 EIB at a glance The EU bank: Established in 1958 Shareholders

More information

MediSapiens Ltd. Because data is not knowledge. 4th of November Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd

MediSapiens Ltd. Because data is not knowledge. 4th of November Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd 4th of November 2014 MediSapiens Ltd Because data is not knowledge Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2014 MediSapiens Ltd. All rights reserved. medisapiens.com MediSapiens Brief

More information

Biobanking and Biomolecular Resources Research Infrastructure: The need for common standards

Biobanking and Biomolecular Resources Research Infrastructure: The need for common standards Biobanking and Biomolecular Resources Research Infrastructure: The need for common standards K. Zatloukal Medical University of Graz, Austria Washington, Embassy of Austria June 5th 2012 Biobanks and Biomolecular

More information

Network-centric Biomedicine: re-engineering the Knowledge Enterprise

Network-centric Biomedicine: re-engineering the Knowledge Enterprise Network-centric Biomedicine: re-engineering the Knowledge Enterprise Ken Buetow, Ph.D. Director Computational Science and Informatics Core Program, Complex Adaptive Systems Initiative Arizona State University

More information

The Need for Scientific. Data Annotation. Alick K Law, Ph.D., M.B.A. Marketing Manager IBM Life Sciences.

The Need for Scientific. Data Annotation. Alick K Law, Ph.D., M.B.A. Marketing Manager IBM Life Sciences. The Need for Scientific Data Annotation Alick K Law, Ph.D., M.B.A. Marketing Manager IBM Life Sciences alaw@us.ibm.com Cross disciplinary research approach requires organizations to address diverse needs

More information

ECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie)

ECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie) ECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT

More information

A regulatory update in a day for Small to Medium-sized Enterprises

A regulatory update in a day for Small to Medium-sized Enterprises TOPRA ANNUAL SYMPOSIUM STOCKHOLM, SWEDEN In partnership with the Swedish Medical Products Agency Time of transformation: Implementing international regulatory change A regulatory update in a day for Small

More information

Biomarkers as an emerging growth area in Denmark

Biomarkers as an emerging growth area in Denmark Biomarkers as an emerging growth area in Denmark International Conference on Perspectives in Precision Medicine, Copenhagen March 1, 2018 Kim Holmstrøm, PhD. Chairman of The Danish Biomarker Network R&D

More information

Synthetic Biology and Patents

Synthetic Biology and Patents Synthetic Biology and Patents Dr. Berthold Rutz, Directorate 2.4.01 Biotechnology European Patent Office Munich "Patenting Synthetic Biology? A Transatlantic Perspective" WWICS, Washington D.C. 30.11.2009

More information

Overview of the Luxembourg biomedical and health research ecosystem FNR FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017

Overview of the Luxembourg biomedical and health research ecosystem FNR FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017 FNR Overview of the Luxembourg biomedical and health research ecosystem FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017 Research in Luxembourg Luxembourg : a young research location Creating structures

More information

EBE White Paper on Personalised Medicine

EBE White Paper on Personalised Medicine EBE White Paper on Personalised Medicine EBE is a specialised group of European Federation of Pharmaceutical Industries and Associations, EFPIA Content p3 p4 p6 p6 p7 p9 p10 p11 p13 p14 Executive Summary

More information

SPECTArare as an innovative model of combining clinical research and care in an ERN. Denis Lacombe, MD, MSc EORTC, Director General Brussels, Belgium

SPECTArare as an innovative model of combining clinical research and care in an ERN. Denis Lacombe, MD, MSc EORTC, Director General Brussels, Belgium SPECTArare as an innovative model of combining clinical research and care in an ERN Denis Lacombe, MD, MSc EORTC, Director General Brussels, Belgium Contents The changing clinical research pathway How

More information

EATRIS accelerates translation of science into medical products that benefit patients and improve human health.

EATRIS accelerates translation of science into medical products that benefit patients and improve human health. OUR PURPOSE EATRIS is a permanent EU biomedical research infrastructure. EATRIS accelerates translation of science into medical products that benefit patients and improve human health. OUR AIMS 1. Improving

More information

Bionure as a success case in the FP7. September, 2012

Bionure as a success case in the FP7. September, 2012 Bionure as a success case in the FP7 September, 2012 Company Bionure is a biotech company that focuses its efforts on the development of new therapies and diagnostic tools for neurological diseases, in

More information

European bioregions : strengths and partnership strategies. The bioxclusters example BioPartnering Latin America cluster forum september 2013

European bioregions : strengths and partnership strategies. The bioxclusters example BioPartnering Latin America cluster forum september 2013 European bioregions : strengths and partnership strategies. The bioxclusters example BioPartnering Latin America cluster forum september 2013 Contents Who we are Our goals Our activities Wha we can offer

More information

Week 1: Discovery Biology Basic knowledge and tools used in Research and Development

Week 1: Discovery Biology Basic knowledge and tools used in Research and Development Downing - Keio Summer School 2018 Healthcare and Biotechnology Course Outline page 1 Strand A: Healthcare and Biotechnology Course Outline This course aims to provide an overview of the current challenges

More information

Planning a national bioinformatics infrastructure investment

Planning a national bioinformatics infrastructure investment Planning a national bioinformatics infrastructure investment 1 Infrastructure? 2 Research infrastructure? 3 Research infrastructure? 4 What is Bioinformatics Infrastructure? What is Bioinformatics Infrastructure?

More information

Inaugural Fraunhofer Delaware Technology Summit

Inaugural Fraunhofer Delaware Technology Summit Inaugural Fraunhofer Delaware Technology Summit Energy and Life Sciences Solu

More information

Data representation for clinical data and metadata

Data representation for clinical data and metadata Data representation for clinical data and metadata WP1: Data representation for clinical data and metadata Inconsistent terminology creates barriers to identifying common clinical entities in disparate

More information

The EORTC Molecular Screening programme SPECTA

The EORTC Molecular Screening programme SPECTA The EORTC Molecular Screening programme SPECTA February 2016 Denis Lacombe, MD, MSc EORTC, Director General Brussels, Belgium The changing shape of clinical research Phase I RESOURCES Phase III The changing

More information

NHS ENGLAND BOARD PAPER

NHS ENGLAND BOARD PAPER NHS ENGLAND BOARD PAPER Paper: PB.30.03.2017/06 Title: Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments Lead Director: Professor Sir Bruce

More information

Duncan Holmes European Head Discovery Partnerships with Academia GlaxoSmithKline

Duncan Holmes European Head Discovery Partnerships with Academia GlaxoSmithKline R&D Strategy Bridging g the academia-industry industry yg gap Duncan Holmes European Head Discovery Partnerships with Academia GlaxoSmithKline GSK at a glance Who we are We are a science-led global healthcare

More information

Our website:

Our website: Biomedical Informatics Summer Internship Program (BMI SIP) The Department of Biomedical Informatics hosts an annual internship program each summer which provides high school, undergraduate, and graduate

More information

MRC Stratified Medicine Initiative

MRC Stratified Medicine Initiative MRC Stratified Medicine Initiative Jonathan Pearce Medical Research Council, Translational Programme Manager Pharmacogenetics and Stratified Medicine Network Conference : 14 th January 2015 Stratified

More information

Chemical education and the pharmaceutical industry*

Chemical education and the pharmaceutical industry* Pure Appl. Chem., Vol. 71, No. 5, pp. 865±870, 1999. Printed in Great Britain. q 1999 IUPAC Chemical education and the pharmaceutical industry* Albert E. Fischli Pharmaceutical Research, F. Hoffmann-LaRoche

More information

EMBL-EBI and pan-national scale bioinformatics: Relevance to Australia

EMBL-EBI and pan-national scale bioinformatics: Relevance to Australia EMBL-EBI and pan-national scale bioinformatics: Relevance to Australia Paul Flicek Vertebrate Genomics, European Molecular Biology Laboratory Wellcome Trust Sanger Institute European Molecular Biology

More information

COMMISSION STAFF WORKING DOCUMENT IMPACT ASSESSMENT. Accompanying the document. Proposal for a Council Regulation

COMMISSION STAFF WORKING DOCUMENT IMPACT ASSESSMENT. Accompanying the document. Proposal for a Council Regulation EUROPEAN COMMISSION Brussels, 11.1.2018 SWD(2018) 6 final PART 3/4 COMMISSION STAFF WORKING DOCUMENT IMPACT ASSESSMENT Accompanying the document Proposal for a Council Regulation on establishing the European

More information

The High Performance Computing strategy and the European Cloud Initiative HPC User Forum September 5-7, 2017 Milwaukee, USA

The High Performance Computing strategy and the European Cloud Initiative HPC User Forum September 5-7, 2017 Milwaukee, USA The High Performance Computing strategy and the European Cloud Initiative HPC User Forum September 5-7, 2017 Milwaukee, USA Leonardo Flores Añover Senior Expert - HPC and Quantum technologies DG CONNECT

More information

Biomedical Informatics in BIG DATA Era

Biomedical Informatics in BIG DATA Era Biomedical Informatics in BIG DATA Era Yang C. Fann, Ph.D. Director, Intramural IT and Bioinformatics Program National Institute of Neurological Disorders and Stroke Disclaimer The opinions or assertions

More information

The Innovate UK response to the Innovative Medicines Initiative consultation Facilitating the translation of advanced therapies to patients in Europe

The Innovate UK response to the Innovative Medicines Initiative consultation Facilitating the translation of advanced therapies to patients in Europe The Innovate UK response to the Innovative Medicines Initiative consultation Facilitating the translation of advanced therapies to patients in Europe Innovate UK and ATMP background 1. Innovate UK is the

More information

Bioinformatics and computational tools

Bioinformatics and computational tools Bioinformatics and computational tools Etienne P. de Villiers (PhD) International Livestock Research Institute Nairobi, Kenya International Livestock Research Institute Nairobi, Kenya ILRI works at the

More information

Achieving Data Liquidity in the Cancer Community: Proposal for a Coalition of All Stakeholders

Achieving Data Liquidity in the Cancer Community: Proposal for a Coalition of All Stakeholders Achieving Data Liquidity in the Cancer Community: Proposal for a Coalition of All Stakeholders Marcia A. Kean, Feinstein Kean Healthcare National Cancer Policy Forum Informatics Needs and Challenges in

More information